If you’re a European investor and you don’t know CSPX, you’ve either been asleep for a decade or you’re still trusting your “safe” high-fee savings account — and bleeding returns. The CSPX ETF (iShares Core S&P 500 UCITS ETF) is, without question, the poster child for global equity exposure in Europe. But here’s the real question for 2026: just because everyone loves it, does that mean you should buy CSPX now?
Let’s not sugarcoat it: CSPX is the S&P 500 tracker of choice for sophisticated Europeans. But markets don’t reward popularity — they reward hard numbers. In this deep dive, I’ll cut through the marketing and crowd-following. What does CSPX offer in 2026, what are the costly pitfalls nobody talks about, and—most importantly—where does your money stand to gain or lose?
What Is CSPX? The S&P 500 Tracker With a European Twist
CSPX (ISIN: IE00B5BMR087) is iShares’ flagship S&P 500 UCITS ETF, domiciled in Ireland. It tracks the S&P 500 index — America’s top 500 companies — but, crucially, it’s structured specifically for European investors. That means no U.S. estate tax risk, Irish tax efficiency, and full UCITS compliance. It’s also EUR-quoted on Xetra and other major European exchanges.
Why does this matter? Because CSPX is designed for efficiency. U.S.-listed S&P 500 ETFs, like Vanguard’s VOO, leave Europeans exposed to a 30% U.S. dividend withholding tax. With CSPX, that’s slashed to 15% thanks to the Ireland-U.S. double tax treaty. And with a total expense ratio (TER) of just 0.07%, CSPX is ruthlessly lean. Compare that to the typical 1.2% fee on a “global equity” active fund sold in European banks — it’s highway robbery.
In 2023, CSPX’s assets surged past €60 billion, outpacing all but a handful of European ETFs — and that’s not just momentum trading, it’s a signal that institutions and retail investors vote for it with their wallets.
For a broader comparison of the best global ETFs for European investors, see our analysis on All-World ETFs like VWCE, IWDA, and CSPX.
Why Do Europeans Flock to CSPX? Hard Numbers, Harder Performance
This isn’t just ETF hype. Since its 2010 launch, CSPX has delivered S&P 500 returns — in EUR terms — with minimal drag. Let’s get specific:
- Five-Year Total Return (EUR, as of May 2026): +83.2%. That’s not a typo. Even after the 2022 Fed panic and 2023’s “recession-that-wasn’t,” CSPX smoked European markets: the Euro Stoxx 50 returned just +48% over the same period.
- Distribution Policy: CSPX is accumulating, not distributing. Dividends are automatically reinvested, compounding over time — maximally tax-efficient for most Europeans. No paperwork, no lost yield.
- Liquidity and Spreads: CSPX trades over €160 million per day on its main listings. Bid-ask spreads are routinely under 0.03%. That’s as close to frictionless as you’ll get.
But CSPX isn’t just about returns. It’s about structural advantages: you avoid U.S. probate disaster, get favorable tax treatment, and hold an asset that’s recognized across every European broker. If you want to dollar-cost average or buy fractional shares, CSPX is available on platforms like Trade Republic and DEGIRO — see our step-by-step CSPX buying guide.
The Bottom Line
CSPX dominates for a reason: low costs, high returns, ironclad tax efficiency. It’s the S&P 500, but smarter for Europeans.
How CSPX Stacks Up Versus Other Equity ETFs
Let’s get brutally honest: other US equity ETFs for Europeans simply don’t compete. CSPX’s direct rivals are typically:
- Acc vs Dist: Some want quarterly cash flow. Fine. But the data is clear: over a 10-year window, accumulating ETFs deliver higher after-tax returns for most European tax regimes. CSPX’s reinvestment policy means you turbocharge compounding.
- Non-UCITS ETFs: If you’re still dabbling in non-UCITS US ETFs, you’re one regulatory crackdown away from a frozen portfolio. UCITS is non-negotiable for 99% of Europeans — and CSPX is textbook compliant.
- Global ETFs: Sure, all-world funds like VWCE or IWDA offer diversification, but their US allocation is only ~60%. If you want pure US equity, CSPX is unmatched. Want to understand the blend approach? See our guide to core-satellite portfolios with CSPX.
Fees? You’d need a microscope to find a cheaper option. Even Vanguard’s VUSA (another S&P 500 UCITS ETF) charges 0.07%, but with slightly less liquidity and less favorable tax reclaim mechanics for some countries. CSPX is the market standard — not just the crowd favorite.
The Case Against CSPX: When It’s NOT the Smart Choice
Let’s put aside the hero worship for a moment. CSPX is not a one-size-fits-all answer. If you’re betting on a eurozone resurgence or want to hedge against USD/EUR volatility, CSPX may set you up for a nasty surprise.
- Currency Risk: CSPX is unhedged. When the euro surges — as in Q1 2023, when EUR/USD jumped 6% — CSPX’s EUR returns get hammered. Want to sleep at night without FX swings? Consider currency-hedged ETFs (see how currency-hedged ETFs work in Europe).
- Home Bias: If your liabilities are in euros and you ignore eurozone equities entirely, you’re gambling on US outperformance forever. Remember: from 2000–2010, the S&P 500 (in EUR) underperformed European stocks by over 40 percentage points.
- Lack of Diversification: CSPX is pure US. If you want the whole world, you’re better off with IWDA, VWCE, or a blend — see our VWCE vs. IWDA comparison for the evidence.
- Valuation Risk: In 2026, the S&P 500’s forward P/E is above 21x, well over its 30-year average. Are you comfortable buying at these stretched levels?
CSPX is not a magic bullet. If the US dollar tanks or US markets finally deflate, CSPX holders will feel every point of pain directly in their portfolios.
CSPX in 2026: Should You Buy, Hold, or Run?
Let’s cut to the chase. CSPX is the best S&P 500 ETF for most European investors—period. Its structure, tax advantages, and relentless cost discipline make it a no-brainer for anyone who wants US equity exposure. But buying CSPX blindly now, at 2026 valuations, is not risk-free. You’re paying for extraordinary US outperformance in the past decade. Reversion to the mean is real.
That said, if you’re building a long-term, dollar-cost averaged portfolio, CSPX still deserves a core spot. But size your US allocation realistically, and don’t be the last one to the index party if US markets stumble. For the right investor, CSPX remains a juggernaut — but for the lazy or complacent, it’s a potential trap.
Here’s my call: If you’re not yet diversified, CSPX should be in your arsenal. Buy, but don’t bet the farm. Rebalance ruthlessly. And if you’re still sitting in cash, wake up — the world’s best companies are compounding, with or without you.
Disclaimer: This article reflects the author's opinion and is for educational purposes only. It does not constitute financial advice. Always do your own research before making investment decisions.